Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Congo declares new Ebola outbreak in north-western province

A new case of Ebola has been confirmed in northwestern Democratic Republic of Congo, prompting health authorities to enforce urgent containment measures just four...

New study shows, longer intervals between COVID-19 vaccinations result in 9 times more protective antibodies

New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study currently being presented at...

Roche awaits approval of EU’s first and only cancer immunotherapy for patients with early-stage NSCLC

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) as...

Hepatitis outbreak in children in Europe and the United States

Health authorities around the world are investigating a mysterious increase in severe cases of hepatitis in young children. More than 130 cases have been...

FDA rejects Ampio’s proposed changes to a phase III study of a pain medication for osteoarthritis

Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee...

SK Chemical, ONCOBIX full-scale collaborative research of innovative new drugs

SK Chemicals said it would start joint research on innovative new drugs with Oncobix, a synthetic new drug developer. Under the accord, Oncobix will derive...
spot_img

Expert Articles

spot_img